Common infusion-related reactions to subcutaneous immunoglobulin therapy: Managing patient expectations

OBJECTIVE: The availability of weekly subcutaneous infusions of subcutaneous immunoglobulin (SCIg) provides an additional therapeutic option for patients with primary immunodeficiency disease. With proper patient education, individuals can safely transition to SCIg therapy and experience minimal sid...

Descripción completa

Detalles Bibliográficos
Autor principal: Wasserman, Richard L.
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770380/
https://www.ncbi.nlm.nih.gov/pubmed/19920958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770380/
https://www.ncbi.nlm.nih.gov/pubmed/19920958

Ejemplares similares